Customer Achieved 20% Reduction in Marketing Overhead, 7% Lift in Patient Acquisition, and 10% Revenue Growth in Q1 2025 With KNOREX XPO

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced that its AI-driven cross-channel marketing platform, KNOREX XPO^SM, has been successfully deployed by one of Canada’s largest dental care networks to accelerate new patient acquisition across more than 450 clinic locations nationwide.

Before implementing KNOREX XPO^SM, the dental network relied on multiple vendors and data systems, resulting in operational inefficiencies and overhead, limited visibility due to siloed data, and rising management costs. These challenges made it increasingly difficult to scale marketing efforts when expanding its rapidly growing footprint.

KNOREX addressed these issues by consolidating all paid media channels—including search, social, and programmatic—into one centralized AI-driven platform. This unified approach enabled the opportunity for cross-channel execution and performance optimization, and real-time visibility across every clinic location, enabled by its seamless united tracking and attribution across these siloed channels.

At the core of this success is KNOREX’s proprietary KAIROS AI engine, which continuously optimized audience targeting, bidding, and dynamically allocating budget in real-time. These automations enabled the network to focus marketing investment on high-intent, new-patient segments, contributing to:

• 7% growth in new patient acquisition in Q1 2025
• 10% increase in revenue in Q1 2025
• 20% reduction in overall marketing costs in Q1 2025

“This collaboration highlights the transformative potential of intelligent automation,” said Justin Tan, Vice President of Business Development of KNOREX. “Our XPO platform doesn’t just streamline marketing—it changes how enterprises grow. By having one pixel to unify tracking and attribution, a single platform interface to automate cross-channel execution thus enabling real-time optimization and consolidating siloed data across multiple channels and platforms, we empower organizations to do more with less while taming the perennial challenge when advertising across multiple channels and platforms. We are off to a good start in delivering a 7% increase in new patient acquisition and double-digit revenue growth proves that AI-driven marketing can translate directly into tangible business results.”

About KNOREX Ltd.

Founded in 2009, KNOREX Ltd. (NYSE American: KNRX) is a B2B technology company that provides AI-driven cross-channel programmatic advertising products and solutions to help businesses to simplify digital marketing. The Company's flagship platform, KNOREX XPO^SM, is an AI-powered, cloud-based advertising technology platform that enables marketers to efficiently plan, execute, and optimize cross-channel ad campaigns across a diverse range of digital media, including social media, search, CTV/OTT, video, audio, display, native, and DOOH advertising.

By leveraging advanced AI/ML-driven automation, KNOREX XPO allows advertisers to enhance campaign performance, reduce wasted ad spend, and scale their marketing efforts while maintaining efficiency and transparency. The platform is designed to address the growing complexity in digital marketing by centralizing campaign execution and analytics into a unified, data-driven workflow.

KNOREX serves global enterprises, agencies, and brands across multiple industries, helping them navigate the rapidly evolving digital advertising landscape with automated, intelligent, and data-driven solutions. The Company has operations in the United States, Vietnam, India, Malaysia, and Singapore.

For additional information, please visit www.knorex.com.

FORWARD-LOOKING STATEMENTS

Certain statements in this press release are “forward-looking statements” as defined under the federal securities laws, including, but not limited to, the Company’s expectations regarding the completion, timing and size of the proposed Offering and statements regarding the use of proceeds from the sale of the Company’s shares in the Offering. These forward-looking statements involve known and unknown risks and uncertainties and are based on the Company’s current expectations and projections about future events that the Company believes may affect its financial condition, results of operations, business strategy and financial needs, including the expectation that the Offering will be successfully completed. Investors can find many (but not all) of these statements by the use of words such as “believe,” “plan,” “expect,” “intend,” “should,” “seek,” “estimate,” “will,” “aim,” and “anticipate,” or other similar expressions in this press release. The Company undertakes no obligation to update or revise publicly any forward-looking statements to reflect subsequent occurring events or circumstances, or changes in its expectations, except as may be required by law. Although the Company believes that the expectations expressed in these forward-looking statements are reasonable, it cannot assure you that such expectations will turn out to be correct, and the Company cautions investors that actual results may differ materially from the anticipated results and encourages investors to review other factors that may affect its future results in the Company’s registration statement and other filings with the SEC.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251209611781/en/